220 related articles for article (PubMed ID: 22450391)
61. Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature.
Kirchhoff TD; Mittendorf T; Schmidt RE; Jablonka A; Merkesdal S
Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):307-17. PubMed ID: 22812555
[TBL] [Abstract][Full Text] [Related]
62. A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Chogle AR; Mishra H; Chakravarty A
J Assoc Physicians India; 2007 May; 55():380; author reply 380-1. PubMed ID: 17844703
[No Abstract] [Full Text] [Related]
63. Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis.
Deodhar A; Yu D
Semin Arthritis Rheum; 2017 Dec; 47(3):343-350. PubMed ID: 28551170
[TBL] [Abstract][Full Text] [Related]
64. Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis.
Arends S; Spoorenberg A; Brouwer E; van der Veer E
Curr Opin Rheumatol; 2014 May; 26(3):259-68. PubMed ID: 24625371
[TBL] [Abstract][Full Text] [Related]
65. BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics.
Hamilton L; Barkham N; Bhalla A; Brittain R; Cook D; Jones G; Mackay K; Marshall D; Marzo-Ortega H; Murphy D; Riddell C; Sengupta R; Siebert S; Van Rossen L; Gaffney K;
Rheumatology (Oxford); 2017 Feb; 56(2):313-316. PubMed ID: 27558584
[No Abstract] [Full Text] [Related]
66. Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?
Yates M; Keat A; Gaffney K
Rheumatology (Oxford); 2016 May; 55(5):769-72. PubMed ID: 26660639
[No Abstract] [Full Text] [Related]
67. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
Toussirot E; Vauchy C; Binda D; Michel F
Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
[TBL] [Abstract][Full Text] [Related]
68. Golimumab for treatment of axial spondyloarthritis.
Rios Rodriguez V; Poddubnyy D
Immunotherapy; 2016 Feb; 8(2):107-15. PubMed ID: 26798943
[TBL] [Abstract][Full Text] [Related]
69. The effect of tumor necrosis factor-blockade on new bone formation in ankylosing spondylitis: what is the evidence?
Haroon N
Curr Opin Rheumatol; 2014 Jul; 26(4):389-94. PubMed ID: 24841228
[TBL] [Abstract][Full Text] [Related]
70. Critical appraisal of the guidelines for the management of ankylosing spondylitis: disease-modifying antirheumatic drugs.
Soriano ER; Clegg DO; Lisse JR
Am J Med Sci; 2012 May; 343(5):357-9. PubMed ID: 22543537
[TBL] [Abstract][Full Text] [Related]
71. Restoration of overexpressed variable heavy chain 2 transcripts with tumor necrosis factor inhibitors in ankylosing spondylitis.
Sheen DH; Kim JY; Lee SY; Lim MK; Yoo SJ; Yoo IS; Kim J; Kang SW; Shim SC
J Rheumatol; 2014 Mar; 41(3):613-4. PubMed ID: 24585525
[No Abstract] [Full Text] [Related]
72. Pharmacological therapy of spondyloarthritis.
Palazzi C; D'Angelo S; Gilio M; Leccese P; Padula A; Olivieri I
Expert Opin Pharmacother; 2015; 16(10):1495-504. PubMed ID: 26073668
[TBL] [Abstract][Full Text] [Related]
73. Established criteria for disease controlling drugs in ankylosing spondylitis.
Gladman DD
Ann Rheum Dis; 2003 Sep; 62(9):793-4. PubMed ID: 12922946
[No Abstract] [Full Text] [Related]
74. Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition.
Juanola X; Ramos MJM; Belzunegui JM; Fernández-Carballido C; Gratacós J
Adv Ther; 2022 Apr; 39(4):1490-1501. PubMed ID: 35201604
[TBL] [Abstract][Full Text] [Related]
75. Structural progression in axial spondyloarthritis.
Aouad K; Ziade N; Baraliakos X
Joint Bone Spine; 2020 Mar; 87(2):131-136. PubMed ID: 31067506
[TBL] [Abstract][Full Text] [Related]
76. Recent advances in the treatment of the spondyloarthropathies.
Liu Y; Cortinovis D; Stone MA
Curr Opin Rheumatol; 2004 Jul; 16(4):357-65. PubMed ID: 15201597
[TBL] [Abstract][Full Text] [Related]
77. New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.
Toussirot E
Expert Opin Pharmacother; 2017 Feb; 18(3):275-282. PubMed ID: 28099816
[TBL] [Abstract][Full Text] [Related]
78. [Early therapy of axial spondyloarthritis and relevance of radiological progression].
Song IH; Sieper J
Z Rheumatol; 2012 Jan; 71(1):38-45. PubMed ID: 22286354
[TBL] [Abstract][Full Text] [Related]
79. Remission in ankylosing spondylitis.
Zochling J; Braun J
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-88-92. PubMed ID: 17083769
[TBL] [Abstract][Full Text] [Related]
80. Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition.
Lekpa FK; Farrenq V; Canouï-Poitrine F; Paul M; Chevalier X; Bruckert R; Bastuji-Garin S; Claudepierre P
Joint Bone Spine; 2012 Jan; 79(1):47-50. PubMed ID: 21497538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
